E-LIB Suche - Ergebnisse für: Sengupta, Shilpa

1

Status of B‐Lymphocyte Subsets and Their Homing Markers in ..:

Sengupta, Shilpa ; Goswami, Deep ; Chakraborty, Bidhan...
Parasite Immunology. 46 (2024) 3 - p. , 2024

2

IgG3 and IL10 are effective biomarkers for monitoring thera..:

Sengupta, Shilpa ; Chatterjee, Mitali ; Schallig, Henk D. F. H.
PLOS Neglected Tropical Diseases. 15 (2021) 11 - p. e0009906 , 2021

Link: https://doi.org/10.1371/..

3

Molecular Tracking of the Leishmania Parasite:

Moulik, Srija ; Sengupta, Shilpa ; Chatterjee, Mitali
Frontiers in Cellular and Infection Microbiology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

4

Immune responses in post kala-azar dermal leishmaniasis:

Chatterjee, Mitali ; Sengupta, Ritika ; Mukhopadhyay, Debanjan...
Indian Journal of Dermatology. 65 (2020) 6 - p. 452 , 2020

Link: https://doi.org/10.4103/..

5

Molecular Tracking of the Leishmania Parasite:

Moulik, Srija ; Sengupta, Shilpa ; Chatterjee, Mitali
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937807/. , 2021

Link: http://www.ncbi.nlm.nih...

6

IgG3 and IL10 are effective biomarkers for monitoring thera..:

Shilpa Sengupta ; Mitali Chatterjee
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580238/?tool=EBI. , 2021

Link: https://doaj.org/article..

7

Molecular Tracking of the Leishmania Parasite:

Srija Moulik ; Shilpa Sengupta ; Mitali Chatterjee
https://www.frontiersin.org/articles/10.3389/fcimb.2021.623437/full. , 2021

Link: https://doi.org/10.3389/..

8

IgG3 and IL10 are effective biomarkers for monitoring thera..:

Shilpa Sengupta ; Mitali Chatterjee
https://doi.org/10.1371/journal.pntd.0009906. , 2021

Link: https://doi.org/10.1371/..

9

Immune responses in post kala-azar dermal leishmaniasis:

Mitali Chatterjee ; Ritika Sengupta ; Debanjan Mukhopadhyay...
http://www.e-ijd.org/article.asp?issn=0019-5154;year=2020;volume=65;issue=6;spage=452;epage=460;aulast=Chatterjee. , 2020

Link: https://doi.org/10.4103/..

10

Study Population:

Shilpa Sengupta (11675550) ; Mitali Chatterjee (323464)
https://figshare.com/articles/dataset/Study_Population_/16984116. , 2021

Link: https://doi.org/10.1371/..

11

Kinetics of IL-10 in PKDL:

Shilpa Sengupta (11675550) ; Mitali Chatterjee (323464)
https://figshare.com/articles/figure/Kinetics_of_IL-10_in_PKDL_/16984110. , 2021

Link: https://doi.org/10.1371/..

12

Fig 2 -:

Shilpa Sengupta (11675550) ; Mitali Chatterjee (323464)
https://figshare.com/articles/figure/Fig_2_-/16984101. , 2021

Link: https://doi.org/10.1371/..

13

Status of dermal lesions in PKDL cases following treatment ..:

Shilpa Sengupta (11675550) ; Mitali Chatterjee (323464)
https://figshare.com/articles/figure/Status_of_dermal_lesions_in_PKDL_cases_following_treatment_with_Miltefosine_or_LAmB_/16984113. , 2021

Link: https://doi.org/10.1371/..

14

S1 Table -:

Shilpa Sengupta (11675550) ; Mitali Chatterjee (323464)
https://figshare.com/articles/journal_contribution/S1_Table_-/16984092. , 2021

Link: https://doi.org/10.1371/..

15

Levels of circulating cytokines following treatment with Mi..:

Shilpa Sengupta (11675550) ; Mitali Chatterjee (323464)
https://figshare.com/articles/figure/Levels_of_circulating_cytokines_following_treatment_with_Miltefosine_or_LAmB_/16984107. , 2021

Link: https://doi.org/10.1371/..